🔎 Trials Near Me

Hem › Lungsjukdomar › Massachusetts

Kliniska studier för Lungsjukdomar i Massachusetts

15 studier för Lungsjukdomar söker deltagare vid platser i Massachusetts.

Städer i Massachusetts

Officiell studietext (engelska)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Dana-Farber Cancer Institute, Boston
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Brigham and Women's Hospital, Boston
  • Lucida Clinical Trials, New Bedford
  • University of Massachusetts Chan Medical School, Worcester
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
  • och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Brigham and Women's Hospital, Boston
RekryterarFas 2
Ålder 40 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Dana Farber Cancer Institute, Boston
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Boston Medical Center, Boston
  • Lahey Hospital & Medical Center, Burlington
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Infinity Medical Research, North Dartmouth
RekryterarFas 3
Ålder 40 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07284602

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Boston
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • Beth Israel Deaconess Medical Center, Boston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 sep. 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 10 juni 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Massachusetts General Hospital,, Boston
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 19 feb. 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 dec. 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

  • Brigham and Women's Hospital, Boston
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2025 · NCT04555161

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.